HomeTrust Mails Definitive Proxy for $416M Blue Ridge Deal; Dec 14 Vote Set
HTB sits 21% above its 52-week low of $38.82.
Summary
HomeTrust's definitive proxy sets the December 14, 2026 shareholder votes on its stock-for-stock purchase of Blue Ridge, with ~8.3 million shares to be issued, ~8% tangible book dilution, and a new lawsuit seeking to block the vote.
Key Events · M&A and Partnerships · HTB
-
Definitive Proxy Filed for Blue Ridge Deal
The joint proxy/prospectus dated October 30, 2026 is being mailed on or about November 9, 2026, ahead of HomeTrust and Blue Ridge special meetings on December 14, 2026.
-
8.3M Shares to Be Issued
HomeTrust expects to issue approximately 8,314,956 shares; former Blue Ridge holders will own about 35% and existing HomeTrust holders about 65% of the combined company.
-
Warrant Elections Quantified
Holders of warrants for 11,356,000 Blue Ridge shares (~47%) agreed to cashless exercise at a locked $4.30 value; 12,759,999 warrants (~53%) will be assumed by HomeTrust.
-
Tangible Book Dilution ~8%
The preliminary purchase price is $415,994 thousand at a $46.19 HomeTrust close on September 25, 2026; expected tangible book value dilution at closing is approximately 8%, with cost savings of ~50% of Blue Ridge's non-interest expense and ~$32.8 million of one-time pre-tax costs.
Analysis · HTB · Finance
The definitive joint proxy/prospectus for HomeTrust's all-stock acquisition of Blue Ridge puts hard numbers on terms previously disclosed only in outline. About 8.3 million shares will be issued, leaving existing holders with roughly 65% of a combined ~$7 billion-asset bank and former Blue Ridge holders with 35% — real dilution, with tangible book value dilution estimated at about 8% at closing. The warrant overhang is now quantified: holders of 11,356,000 Blue Ridge warrant shares (~47%) locked in cashless exercise at a $4.30 reference value, while 12,759,999 (~53%) will be assumed by HomeTrust. A new shareholder suit filed October 19, 2026 seeks to enjoin the December 14 vote, which is the gating event alongside regulatory approvals; closing is targeted for early Q1 2027.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HTB was trading at $47.04 on NYSE in the Finance sector, with a market capitalization of approximately $744M. The 52-week trading range was $38.82 to $52.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.